Animal models of allergic bronchopulmonary aspergillosis

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Grunig, Gabriele ^a   Kurup, Viswanath P ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b NONE

Author keywords

ABPA; Allergic Bronchopulmonary Aspergillosis; Animal Models; B cells; Chemokine Receptors; Chemokines; Cytokines; Eosinophils; IFN gamma; IL 13; Review; T cells

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; RANTES;

ANTIBODY PRODUCTION; ASPERGILLUS FUMIGATUS; BRONCHUS HYPERREACTIVITY; CELLULAR IMMUNITY; CONIDIUM; CYTOKINE RELEASE; EOSINOPHIL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; LUNG ASPERGILLOSIS; NONHUMAN; PNEUMONIA; REVIEW; T LYMPHOCYTE;

ANIMALIA; ASPERGILLUS; ASPERGILLUS FUMIGATUS; BRONCHUS; INSERTION SEQUENCES;

EID: 3142677331     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (127)

1. Kurup V.P. & A.J. Apter: Allergic bronchopulmonary aspergillosis. In Immunology and Allergy Clinics of North America. V.P. Kurup & A.J. Apter, eds, Vol. 18, p 471-715 (1998)
2. Summerbell R.C.: Taxonomy and ecology of Aspergillus species associated with colonizing infections of the respiratory tract. In Immunology and Allergy Clinics of North America. V.P. Kurup & A. A.J., eds, Vol. 18, p 549-573 (1998)
3. Gravesen S., L. Larsen, F. Gyntelberg & P. Skov: Demonstration of microorganisms and dust in schools and offices. An observational study of non-industrial buildings. Allergy 41, 520-525. (1986)
4. Gravesen S., P.A. Nielsen, R. Iversen & K.F. Nielsen: Microfungal contamination of damp buildings - examples of risk constructions and risk materials. Environ Health Perspect 107 Suppl 3, 505-508. (1999)
5. Haverinen U., T. Husman, M. Toivola, J. Suonketo, M. Pentti, R. Lindberg, J. Leinonen, A. Hyvarinen, T. Meklin & A. Nevalainen: An approach to management of critical indoor air problems in school buildings. Environ Health Perspect 107 Suppl 3, 509-514. (1999)
6. Lander F., H.W. Meyer & S. Norn: Serum IgE specific to indoor moulds, measured by basophil histamine release, is associated with building-related symptoms in damp buildings. Inflamm Res 50, 227-231. (2001)
7. Kistemann T., H. Huneburg, M. Exner, V. Vacata & S. Engelhart: Role of increased environmental Aspergillus exposure for patients with chronic obstructive pulmonary disease (COPD) treated with corticosteroids in an intensive care unit. Int J Hyg Environ Health 204, 347-351. (2002)
8. Gravesen S.: Microbiology on indoor air '99 - what is new and interesting? An overview of selected papers presented in Edinburgh, August, 1999. Indoor Air 10, 74-80. (2000)
9. Greenberger P.A.: Diagnosis and management of allergic bronchopulmonary aspergillosis. Allergy Proc 15, 335-339. (1994)
10. Eppinger T.M., P.A. Greenberger, D.A. White, A.E. Brown & C. Cunningham-Rundles: Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J Allergy Clin Immunol 104, 1265-1272. (1999)
11. Greenberger P.A.: Immunologic aspects of lung diseases and cystic fibrosis. Jama 278, 1924-1930. (1997)
12. Holding K.J., M.S. Dworkin, P.C. Wan, D.L. Hanson, R.M. Klevens, J.L. Jones & P.S. Sullivan: Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and Adolescent Spectrum of HIV Disease Project. Clin Infect Dis 31, 1253-1257. (2000)
13. Walsh T.J. & A.H. Groll: Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis 1, 247-261. (1999)
14. Kurup V.P., G. Grunig, A.P. Knutsen & P.S. Murali: Cytokines in allergic bronchopulmonary aspergillosis. Res Immunol 149, 466-477; discussion 515-466. (1998)
15. Kurup V.P. & B. Banerjee: Allergic aspergillosis: Antigens and immunodiagnosis. In Advances in Medical Mycology. O.P. Srivasstava, A.K. Srivasstava & P. Shukla, eds, Vol. 2, p 133-154 (1996)
16. Knutsen A.P., K.R. Mueller, A.D. Levine, B. Chouhan, P.S. Hutcheson & R.G. Slavin: Asp f I CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 94, 215-221. (1994)
17. Knutsen A.P., K.R. Mueller, P.S. Hutcheson & R.G. Slavin: T- and B-cell dysregulation of IgE synthesis in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Clin Immunol Immunopathol 55, 129-138. (1990)
18. Rathore V.B., B. Johnson, J.N. Fink, K.J. Kelly, P.A. Greenberger & V.P. Kurup: T cell proliferation and cytokine secretion to T cell epitopes of Asp f 2 in ABPA patients. Clin Immunol 100, 228-235. (2001)
19. Kurup V.P., B. Banerjee, S. Hemmann, P.A. Greenberger, K. Blaser & R. Crameri: Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 30, 988-993. (2000)
20. Murali P.S., V.P. Kurup, N.K. Bansal, J.N. Fink & P.A. Greenberger: IgE down regulation and cytokine induction by Aspergillus antigens in human allergic bronchopulmonary aspergillosis. J Lab Clin Med 131, 228-235. (1998)
21. Greenberger P.A.: Allergic bronchopulmonary aspergillosis, allergic fungal sinusitis, and hypersensitivity pneumonitis. Clin Allergy Immunol 16, 449-468 (2002)
22. Laufer P., J.N. Fink, W.T. Bruns, G.F. Unger, J.H. Kalbfleisch, P.A. Greenberger & R. Patterson: Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 73, 44-48. (1984)
23. Nelson L.A., M.L. Callerame & R.H. Schwartz: Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis 120, 863-873. (1979)
24. Patterson R., P.A. Greenberger, J.M. Halwig, J.L. Liotta & M. Roberts: Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146, 916-918. (1986)
25. Brown J.E., P.A. Greenberger & P.R. Yarnold: Soluble serum interleukin 2 receptors in patients with asthma and allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 74, 484-488. (1995)
26. Kurup V.P., A. Resnick, J. Kalbfleish & J.N. Fink: Antibody isotype responses in Aspergillus-induced diseases. J Lab Clin Med 115, 298-303. (1990)
27. Hogaboam C.M., K. Blease, B. Mehrad, M.L. Steinhauser, T.J. Standiford, S.L. Kunkel & N.W. Lukacs: Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 156, 723-732. (2000)
28. Kurup V.P., B.W. Seymour, H. Choi & R.L. Coffman: Particulate Aspergillus fumigatus antigens elicit a TH2 response in BALB/c mice. J Allergy Clin Immunol 93, 1013-1020. (1994)
29. Kurup V.P., J. Guo, P.S. Murali, H. Choi & J.N. Fink: Immunopathologic responses to Aspergillus antigen in interleukin-4 knockout mice. J Lab Clin Med 130, 567-575. (1997)
30. Schuh J.M., K. Blease & C.M. Hogaboam: CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J Immunol 168, 1447-1456. (2002)
31. Blease K., B. Mehrad, T.J. Standiford, N.W. Lukacs, J. Gosling, L. Boring, I.F. Charo, S.L. Kunkel & C.M. Hogaboam: Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice. J Immunol 165, 2603-2611. (2000)
32. Blease K., J.M. Schuh, C. Jakubzick, N.W. Lukacs, S.L. Kunkel, B.H. Joshi, R.K. Puri, M.H. Kaplan & C.M. Hogaboam: Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol 160, 481-490. (2002)
33. Murali P.S., B.S. Bamrah, H. Choi, J.N. Fink & V.P. Kurup: Hyperimmune serum modulates allergic response to spores in a murine model of allergic aspergillosis. J Leukoc Biol 55, 29-34. (1994)
34. Kurup V.P., H. Choi, P.S. Murali, A. Resnick, J.N. Fink & R.L. Coffman: Role of particulate antigens of Aspergillus in murine eosinophilia. Int Arch Allergy Immunol 112, 270-278. (1997)
35. Kurup V.P., S. Mauze, H. Choi, B.W. Seymour & R.L. Coffman: A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J Immunol 148, 3783-3788. (1992)
36. Kurup V.P., P.S. Murali, J. Guo, H. Choi, B. Banerjee, J.N. Fink & R.L. Coffman: Anti-interleukin (IL)-4 and -IL-5 antibodies downregulate IgE and eosinophilia in mice exposed to Aspergillus antigens. Allergy 52, 1215-1221. (1997)
37. Chu H.W., J.M. Wang, M. Boutet, L.P. Boulet & M. Laviolette: Increased expression of intercellular adhesion molecule-1 (ICAM-1) in a murine model of pulmonary eosinophilia and high IgE level. Clin Exp Immunol 100, 319-324. (1995)
38. Chu H.W., J.M. Wang, M. Boutet, L.P. Boulet & M. Laviolette: Immunohistochemical detection of GM-CSF, IL-4 and IL-5 in a murine model of allergic bronchopulmonary aspergillosis. Clin Exp Allergy 26, 461-468. (1996)
39. Chu H.W., J.M. Wang, M. Boutet & M. Laviolette: Tumor necrosis factor-alpha and interleukin-1 alpha expression in a murine model of allergic bronchopulmonary aspergillosis. Lab Anim Sci 46, 42-47. (1996)
40. Kurup V.P., M. Ramasamy, P.A. Greenberger & J.N. Fink: Isolation and characterization of a relevant Aspergillus fumigatus antigen with IgG- and IgE-binding activity. Int Arch Allergy Appl Immunol 86, 176-182 (1988)
41. Kurup V.P., A. Resnick, G.H. Scribner, M. Gunasekaran & J.N. Fink: Enzyme profile and immunochemical characterization of Aspergillus fumigatus antigens. J Allergy Clin Immunol 78, 1166-1173. (1986)
42. Grunig G., D.B. Corry, M.W. Leach, B.W. Seymour, V.P. Kurup & D.M. Rennick: Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185, 1089-1099. (1997)
43. Tomee J.F., A.T. Wierenga, P.S. Hiemstra & H.K. Kauffman: Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 176, 300-303. (1997)
44. Amitani R., G. Taylor, E.N. Elezis, C. Llewellyn-Jones, J. Mitchell, F. Kuze, P.J. Cole & R. Wilson: Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 63, 3266-3271. (1995)
45. Goldstein G.B., H. Park & M. Yokoyama: Studies of the precipitating antibody response in pulmonary aspergillosis. Int Arch Allergy Appl Immunol 44, 1-10 (1973)
46. Comoy E.E., J. Pestel, C. Duez, G.A. Stewart, C. Vendeville, C. Fournier, F. Finkelman, A. Capron & G. Thyphronitis: The house dust mite allergen, Dermatophagoides pteronyssinus, promotes type 2 responses by modulating the balance between 1L-4 and IFN-gamma. J Immunol 160, 2456-2462. (1998)
47. Knutsen A.P., B. Chauhan & R.G. Slavin: Cell-mediated immunity in allergic bronchopulmonary aspergillosis. In Immunology and Allergy Clinics of North America. V.P. Kurup & A.J. Apter, eds, Vol. 18, p 575-599 (1998)
48. Killer R., S. Laffer, C. Harwanegg, M. Huber, W.M. Schmidt, A. Twardosz, B. Barletta, W.M. Becker, K. Blaser, H. Breiteneder, M. Chapman, R. Crameri, M. Duchene, F. Ferreira, H. Fiebig, K. Hoffmann-Sommergruber, T.P. King, T. Kleber-Janke, V.P. Kurup, S.B. Lehrer, J. Lidholm, U. Muller, C. Pini, G. Reese, O. Scheiner, A. Scheynius, H.D. Shen, S. Spitzauer, R. Suck, I. Swoboda, W. Thomas, R. Tinghino, M. Van Hage-Hamsten, T. Virtanen, D. Kraft, M.W. Muller & R. Valenta: Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. Faseb J 16, 414-416. (2002)
49. Walker C., W. Bauer, R.K. Braun, G. Menz, P. Braun, F. Schwarz, T.T. Hansel & B. Villiger: Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 150, 1038-1048. (1994)
50. Chapman B.J., S. Capewell, R. Gibson, A.P. Greening & G.K. Crompton: Pulmonary eosinophilia with and without allergic bronchopulmonary aspergillosis. Thorax 44, 919-924. (1989)
51. Arruda L.K., T.A. Platts-Mills, J.L. Longbottom, J.M. el-Dahr & M.D. Chapman: Aspergillus fumigatus: identification of 16, 18, and 45 kd antigens recognized by human IgG and IgE antibodies and murine monoclonal antibodies. J Allergy Clin Immunol 89, 1166-1176. (1992)
52. Chauhan B., A. Knutsen, P.S. Hutcheson, R.G. Slavin & C.J. Bellone: T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 91, 2324-2331. (1996)
53. Corry D.B., G. Grunig, H. Hadeiba, V.P. Kurup, M.L. Warnock, D. Sheppard, D.M. Rennick & R.M. Locksley: Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 4, 344-355. (1998)
54. Blease K., B. Mehrad, T.J. Standiford, N.W. Lukacs, S.L. Kunkel, S.W. Chensue, B. Lu, C.J. Gerard & C.M. Hogaboam: Airway remodeling is absent in CCR1l-/- mice during chronic fungal allergic airway disease. J Immunol 165, 1564-1572. (2000)
55. Wang J.M., M. Denis, M. Fournier & M. Laviolette: Experimental allergic bronchopulmonary aspergillosis in the mouse: immunological and histological features. Scand J Immunol 39, 19-26. (1994)
56. Mehlhop P.D., M. van de Rijn, A.B. Goldberg, J.P. Brewer, V.P. Kurup, T.R. Martin & H.C. Oettgen: Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A 94, 1344-1349. (1997)
57. Corry D.B., K. Rishi, J. Kanellis, A. Kiss, L.Z. Song Lz, J. Xu, L. Feng, Z. Werb & F. Kheradmand: Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol 3, 347-353. (2002)
58. Schuh J.M., K. Blease & C.M. Hogaboam: The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice. Faseb J 16, 228-230. (2002)
59. Blease K., C. Jakubzick, J.M. Schuh, B.H. Joshi, R.K. Puri & C.M. Hogaboam: IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice. J Immunol 167, 6583-6592. (2001)
60. Blease K., C. Jakubzick, J. Westwick, N. Lukacs, S.L. Kunkel & C.M. Hogaboam: Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol 166, 5219-5224. (2001)
61. Ford J.G., D. Rennick, D.D. Donaldson, R. Venkayya, C. McArthur, E. Hansell, V.P. Kurup, M. Warnock & G. Grunig: I1-13 and IFN-gamma: interactions in lung inflammation. J Immunol 167, 1769-1777. (2001)
62. Kurup V.P., H.Y. Choi, P.S. Murali, J.Q. Xia, R.L. Coffman & J.N. Fink: Immune responses to Aspergillus antigen in IL-4-/-mice and the effect of eosinophil ablation. Allergy 54, 420-427. (1999)
63. Takeyama K., K. Dabbagh, H.M. Lee, C. Agusti, J.A. Lausier, I.F. Ueki, K.M. Grattan & J.A. Nadel: Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci U S A 96, 3081-3086. (1999)
64. Nakanishi A., S. Morita, H. Iwashita, Y. Sagiya, Y. Ashida, H. Shirafuji, Y. Fujisawa, O. Nishimura & M. Fujino: Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci U S A 98, 5175-5180. (2001)
65. Drouin S.M., D.B. Corry, J. Kildsgaard & R.A. Wetsel: Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J Immunol 167, 4141-4145. (2001)
66. Blease K., S.L. Kunkel & C.M. Hogaboam: IL-18 modulates chronic fungal asthma in a murine model; putative involvement of Toll-like receptor-2. Inflamm Res 50, 552-560. (2001)
67. Wang J.E., A. Warris, E.A. Ellingsen, P.F. Jorgensen, T.H. Flo, T. Espevik, R. Solberg, P.E. Verweij & A.O. Aasen: Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun 69, 2402-2406. (2001)
68. Lee J.H., N. Kaminski, G. Dolganov, G. Grunig, L. Koth, C. Solomon, D.J. Erle & D. Sheppard: Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am J Respir Cell Mol Biol 25, 474-485. (2001)
69. Mosmann T.R. & R.L. Coffman: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7, 145-173 (1989)
70. Abbas A.K., K.M. Murphy & A. Sher: Functional diversity of helper T lymphocytes. Nature 383, 787-793 (1996)
71. O'Garra A.: Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8, 275-283. (1998)
72. Donaldson D.D., M.J. Whitters, L.J. Fitz, T.Y. Neben, H. Finnerty, S.L. Henderson, R.M. O'Hara, Jr., D.R. Beier, K.J. Turner, C.R. Wood & M. Collins: The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 161, 2317-2324 (1998)
73. Urban J.F., Jr., N. Noben-Trauth, D.D. Donaldson, K.B. Madden, S.C. Morris, M. Collins & F.D. Finkelman: IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8, 255-264 (1998)
74. Wills-Karp M., J. Luyimbazi, X. Xu, B. Schofield, T.Y. Neben, C.L. Karp & D.D. Donaldson: Interleukin-13: central mediator of allergic asthma [see comments]. Science 282, 2258-2261 (1998)
75. Grunig G., M. Warnock, A.E. Wakil, R. Venkayya, F. Brombacher, D.M. Rennick, D. Sheppard, M. Mohrs, D.D. Donaldson, R.M. Locksley & D.B. Corry: Requirement for IL-13 Independently of IL-4 in Experimental Asthma. Science 282, 2261-2263 (1998)
76. Zurawski G. & J.E. de Vries: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15, 19-26. (1994)
77. Donaldson D.D., J.A. Elias & M. Wills-Karp: IL-13 Antagonism for Pulmonary Inflammatory Disease. In New Drugs for Asthma, Allergy and COPD. T. Hansel & P. Barnes, eds. Karger, Basel, Vol. 312000)
78. Donaldson D.D., M.J. Whitters, L.J. Fitz, T.Y. Neben, H. Finnerty, S.L. Henderson, R.M. O'Hara, Jr., D.R. Beier, K.J. Turner, C.R. Wood & M. Collins: The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 161, 2317-2324. (1998)
79. Zhu Z., R.J. Homer, Z. Wang, Q. Chen, G.P. Geba, J. Wang, Y. Zhang & J.A. Elias: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103, 779-788 (1999)
80. Zimmermann N., S.P. Hogan, A. Mishra, E.B. Brandt, T.R. Bodette, S.M. Pope, F.D. Finkelman & M.E. Rothenberg: Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 165, 5839-5846. (2000)
81. Nagata M., J.B. Sedgwick, H. Kita & W.W. Busse: Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am J Respir Cell Mol Biol 19, 158-166. (1998)
82. Bonfield T.L., M.W. Konstan, P. Burfeind, J.R. Panuska, J.B. Hilliard & M. Berger: Normal bronchial epithelial cells constitutively produce the antiinflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 13, 257-261. (1995)
83. Davidson N.J., M.W. Leach, M.M. Fort, L. Thompson-Snipes, R. Kuhn, W. Muller, D.J. Berg & D.M. Rennick: T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184, 241-251. (1996)
84. de Waal Malefyt R., C.G. Figdor & J.E. de Vries: Regulation of human monocyte functions by Interleukin-10. In Interleukin-10. J.E. de Vries & R. de Waal Malefyt, eds. Springer-Verlag,, Heidelberg, p 37-52 (1995)
85. Akbari O., R.H. DeKruyff & D.T. Umetsu: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2, 725-731. (2001)
86. Soltys J., T. Bonfield, J. Chmiel & M. Berger: Functional IL-10 deficiency in the lung of cystic fibrosis (cftr(-/-)) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophages. J Immunol 168, 1903-1910. (2002)
87. Groux H., A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. de Vries & M.G. Roncarolo: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742. (1997)
88. Asseman C., S. Mauze, M.W. Leach, R.L. Coffman & F. Powrie: An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190, 995-1004. (1999)
89. Barrat F.J., D.J. Cua, A. Boonstra, D.F. Richards, C. Crain, H.F. Savelkoul, R. de Waal-Malefyt, R.L. Coffman, C.M. Hawrylowicz & A. O'Garra: In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195, 603-616. (2002)
90. Clemons K.V., G. Grunig, R.A. Sobel, L.F. Mirels, D.M. Rennick & D.A. Stevens: Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol 122, 186-191. (2000)
91. Korsgren M., J.S. Erjefalt, O. Korsgren, F. Sundler & C.G. Persson: Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 185, 885-892. (1997)
92. Hamelmann E., A.T. Vella, A. Oshiba, J.W. Kappler, P. Marrack & E.W. Gelfand: Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc Natl Acad Sci U S A 94, 1350-1355. (1997)
93. Slavin R.G., V.W. Fischer, E.A. Levine, C.C. Tsai & P. Winzenburger: A primate model of allergic bronchopulmonary aspergillosis. Int Arch Allergy Appl Immunol 56, 325-333 (1978)
94. Coyle A.J., K. Wagner, C. Bertrand, S. Tsuyuki, J. Bews & C. Heusser: Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med 183, 1303-1310. (1996)
95. Moulin V., F. Andris, K. Thielemans, C. Maliszewski, J. Urbain & M. Moser: B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med 192, 475-482. (2000)
96. Hamano Y., H. Arase, H. Saisho & T. Saito: Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J Immunol 164, 6113-6119. (2000)
97. Murali P.S., G. Dai, A. Kumar, J.N. Fink & V.P. Kurup: Aspergillus antigen-induced eosinophil differentiation in a murine model. Infect Immun 60, 1952-1956. (1992)
98. Murali P.S., A. Kumar, H. Choi, N.K. Banasal, J.N. Fink & V.P. Kurup: Aspergillus fumigatus antigen induced eosinophilia in mice is abrogated by anti-IL-5 antibody. J Leukoc Biol 53, 264-267. (1993)
99. Murali P.S., V.P. Kurup, J. Guo & J.N. Fink: Development of bone marrow eosinophilia in mice induced by Aspergillus fumigatus antigens. Clin Immunol Immunopathol 84, 216-220. (1997)
100. Hogaboam C.M., C.S. Gallinat, D.D. Taub, R.M. Strieter, S.L. Kunkel & N.W. Lukacs: Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis. J Immunol 162, 6071-6079. (1999)
101. Blease K., B. Mehrad, N.W. Lukacs, S.L. Kunkel, T.J. Standiford & C.M. Hogaboam: Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia. J Immunol 166, 1832-1842. (2001)
102. Li L., Y. Xia, A. Nguyen, Y.H. Lai, L. Feng, T.R. Mosmann & D. Lo: Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 162, 2477-2487. (1999)
103. Qiu B., K.A. Frait, F. Reich, E. Komuniecki & S.W. Chensue: Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am J Pathol 158, 1503-1515. (2001)
104. Orlofsky A., Y. Wu & M.B. Prystowsky: Divergent regulation of the murine CC chemokine C10 by Th(1) and Th(2) cytokines. Cytokine 12, 220-228. (2000)
105. Nagai H., J. Guo, H. Choi & V. Kurup: Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J Infect Dis 172, 1554-1560. (1995)
106. Cenci E., A. Mencacci, G. Del Sero, A. Bacci, C. Montagnoli, C.F. d'Ostiani, P. Mosci, M. Bachmann, F. Bistoni, M. Kopf & L. Romani: Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis 180, 1957-1968. (1999)
107. Cenci E., A. Mencacci, C. Fe d'Ostiani, G. Del Sero, P. Mosci, C. Montagnoli, A. Bacci & L. Romani: Cytokine-and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 178, 1750-1760. (1998)
108. Cenci E., A. Mencacci, A. Bacci, F. Bistoni, V.P. Kurup & L. Romani: T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 165, 381-388. (2000)
109. Zlotnik A. & O. Yoshie: Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127. (2000)
110. Mehrad B., R.M. Strieter, T.A. Moore, W.C. Tsai, S.A. Lira & T.J. Standiford: CXC chemokine receptor-2 ligands are necessary components of neutrophil- mediated host defense in invasive pulmonary aspergillosis. J Immunol 163, 6086-6094. (1999)
111. Moser M., R. Crameri, G. Menz, T. Schneider, T. Dudler, C. Virchow, M. Gmachl, K. Blaser & M. Suter: Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type 1 skin test activity. J Immunol 149, 454-460. (1992)
112. Moser M., G. Menz, K. Blaser & R. Crameri: Recombinant expression and antigenic properties of a 32-kilodalton extracellular alkaline protease, representing a possible virulence factor from Aspergillus fumigatus. Infect Immun 62, 936-942. (1994)
113. Arruda L.K., B.J. Mann & M.D. Chapman: Selective expression of a major allergen and cytotoxin, Asp f I, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus-related diseases. J Immunol 149, 3354-3359. (1992)
114. Kumar A., L.V. Reddy, A. Sochanik & V.P. Kurup: Isolation and characterization of a recombinant heat shock protein of Aspergillus fumigatus. J Allergy Clin Immunol 91, 1024-1030. (1993)
115. Crameri R. & K. Blaser: Cloning Aspergillus fumigatus allergens by the pJuFo filamentous phage display system. Int Arch Allergy Immunol 110, 41-45. (1996)
116. Banerjee B., V.P. Kurup, S. Phadnis, P.A. Greenberger & J.N. Fink: Molecular cloning and expression of a recombinant Aspergillus fumigatus protein Asp f II with significant immunoglobulin E reactivity in allergic bronchopulmonary aspergillosis. J Lab Clin Med 127, 253-262. (1996)
117. Mayer C., S. Hemmann, A. Faith, K. Blaser & R. Crameri: Cloning, production, characterization and IgE cross-reactivity of different manganese superoxide dismutases in individuals sensitized to Aspergillus fumigatus. Int Arch Allergy Immunol 113, 213-215. (1997)
118. Banerjee B., V.P. Kurup, P.A. Greenberger, B.D. Johnson & J.N. Fink: Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell-mediated immunity in allergic bronchopulmonary aspergillosis (ABPA). Clin Exp Allergy 31, 761-770. (2001)
119. Fluckiger S., H. Fijten, P. Whitley, K. Blaser & R. Crameri: Cyclophilins, a new family of cross-reactive allergens. Eur J Immunol 32, 10-17. (2002)
120. Fluckiger S., P.R. Mittl, L. Scapozza, H. Fijten, G. Folkers, M.G. Grutter, K. Blaser & R. Crameri: Comparison of the crystal structures of the human manganese superoxide dismutase and the homologous Aspergillus fumigatus allergen at 2-A resolution. J Immunol 168, 1267-1272. (2002)
121. Kurup V.P., J.Q. Xia, R. Crameri, D.A. Rickaby, H.Y. Choi, S. Fluckiger, K. Blaser, C.A. Dawson & K.J. Kelly: Purified recombinant A. fumigatus allergens induce different responses in mice. Clin Immunol 98, 327-336. (2001)
122. Svirshchevskaya E., E. Frolova, L. Alekseeva, O. Kotzareva & V.P. Kurup: Intravenous injection of major and cryptic peptide epitopes of ribotoxin, Asp f 1 inhibits T cell response induced by crude Aspergillus fumigatus antigens in mice. Peptides 21, 1-8. (2000)
123. Tang B., B. Banerjee, P.A. Greenberger, J.N. Fink, K.J. Kelly & V.P. Kurup: Antibody binding of deletion mutants of Asp f 2, the major Aspergillus fumigatus allergen. Biochem Biophys Res Commun 270, 1128-1135. (2000)
124. Kurup V.P., V. Hari, J. Guo, P.S. Murali, A. Resnick, M. Krishnan & J.N. Fink: Aspergillus fumigatus peptides differentially express Th1 and Th2 cytokines. Peptides 17, 183-190 (1996)
125. Kline J.N., T.J. Waldschmidt, T.R. Businga, J.E. Lemish, J.V. Weinstock, P.S. Thorne & A.M. Krieg: Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 160, 2555-2559. (1998)
126. Kline J.N., A.M. Krieg, T.J. Waldschmidt, Z.K. Ballas, V. Jain & T.R. Businga: CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol 104, 1258-1264. (1999)
127. Banerjee B., J.-Q. Xia, D.A. Rickaby, J.D. Henderson, K.J. Kelly, J.N. Fink & V.P. Kurup: Modulation of airway inflammation by immunostimulatory CpG oligodeoxy nucleotide in a murine model of allergic aspergillosis (abstract). J Allergy Clin Immunol 107, S216 (2001)